Location History:
- Lawerence, KS (US) (2017)
- St. Paul, MS (US) (2020)
- Lawrence, KS (US) (2002 - 2023)
Company Filing History:
10 out of 547 
2 out of 17 
2 out of 3,539 
Years Active: 2002-2024
Title: Sunil Abraham David: Innovator in Antiviral Compounds and TLR Modulators
Introduction
Sunil Abraham David, an accomplished inventor based in Lawrence, KS, has significantly contributed to the field of medical science with an impressive portfolio of 13 patents. His research primarily focuses on developing innovative compounds that can serve as modulators for human toll-like receptors and antiviral agents.
Latest Patents
Among Sunil's latest innovations are two notable patents. The first revolves around human TLR8-selective agonists, which are designed to modulate human toll-like receptors, exhibiting potential therapeutic applications. The patent discloses compounds of general Formula (II), detailing specific designations for the components involved. The second patent deals with antiviral compounds, which includes a comprehensive chemical structure that features various derivatives and modifications. These antiviral compounds aim to provide effective solutions in antiviral therapies, making a notable impact in the pharmaceutical sector.
Career Highlights
Throughout his career, Sunil has worked with prestigious organizations, including the University of Kansas and Mediquest Therapeutics, Inc. His tenure at these institutions has allowed him to harness his expertise in research and innovation, leading to the development of groundbreaking patents.
Collaborations
Sunil has collaborated with talented individuals in his field, including coworkers Nikunj Shukla and Mark R. Burns. Their collective efforts have contributed to advancements in therapeutic compounds and enhanced the potential for novel treatments in various medical applications.
Conclusion
Sunil Abraham David stands as a prominent figure in the landscape of scientific innovation. With his groundbreaking patents and dedicated career, he continues to pave the way for future advancements in antiviral therapies and immunomodulation. His work not only signifies innovation but also the relentless pursuit of improving human health through science.